Literature DB >> 266176

Age incidence curves for cancer.

G S Watson.   

Abstract

Age incidence curves for carcinomas tend to be linear on doubly logarithmic graphs. This fact has been used to support the somatic mutation hypothesis. It is shown that this should also be expected on the epigenetic hypothesis when the reversible cellular changes are programmed to occur randomly. Such changes could be programmed differently to obtain the age incidence curves observed for other cancers, e.g., leukemias and sarcomas.

Entities:  

Mesh:

Year:  1977        PMID: 266176      PMCID: PMC430750          DOI: 10.1073/pnas.74.4.1341

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  4 in total

1.  A method of analysis of a certain class of experiments in carcinogenesis.

Authors:  M C Pike
Journal:  Biometrics       Date:  1966-03       Impact factor: 2.571

2.  Fundamental carcinogenic processes and their implications for low dose risk assessment.

Authors:  K S Crump; D G Hoel; C H Langley; R Peto
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

3.  Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts.

Authors:  K Illmensee; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

4.  Normal genetically mosaic mice produced from malignant teratocarcinoma cells.

Authors:  B Mintz; K Illmensee
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

  4 in total
  3 in total

1.  Mathematical models in oncology: a bird's-eye view.

Authors:  P Tautu
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978

Review 2.  Clinical implications of current studies in carcinogenesis.

Authors:  B A Ponder
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

3.  Bioactuarial models of national mortality time series data.

Authors:  K G Manton; E Stallard
Journal:  Health Care Financ Rev       Date:  1982-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.